Common Stock, Shares Authorized of Hypha Labs, Inc. from Q2 2011 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Hypha Labs, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q2 2011 to Q2 2025.
  • Hypha Labs, Inc. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 880,000,000, a 252% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Hypha Labs, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 880,000,000 +630,000,000 +252% 30 Jun 2025 10-Q 21 Aug 2025 2025 Q3
Q1 2025 880,000,000 +630,000,000 +252% 31 Mar 2025 10-Q 13 Jun 2025 2025 Q2
Q4 2024 250,000,000 0 0% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 880,000,000 +630,000,000 +252% 30 Sep 2024 10-Q 21 Aug 2025 2025 Q3
Q2 2024 250,000,000 0 0% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 250,000,000 0 0% 31 Mar 2024 10-Q 20 May 2024 2024 Q2
Q4 2023 250,000,000 0 0% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 250,000,000 0 0% 30 Sep 2023 10-K 13 Jan 2025 2024 FY
Q2 2023 250,000,000 0 0% 30 Jun 2023 10-Q 18 Aug 2023 2023 Q3
Q1 2023 250,000,000 0 0% 31 Mar 2023 10-Q 26 May 2023 2023 Q2
Q4 2022 250,000,000 0 0% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 250,000,000 0 0% 30 Sep 2022 10-K/A 19 Jan 2024 2023 FY
Q2 2022 250,000,000 0 0% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q1 2022 250,000,000 0 0% 31 Mar 2022 10-Q 16 May 2022 2022 Q2
Q4 2021 250,000,000 0 0% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 250,000,000 0 0% 30 Sep 2021 10-K 17 Jan 2023 2022 FY
Q2 2021 250,000,000 0 0% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 250,000,000 0 0% 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 250,000,000 0 0% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q1
Q3 2020 250,000,000 0 0% 30 Sep 2020 10-K 29 Dec 2021 2021 FY
Q2 2020 250,000,000 0 0% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 250,000,000 +160,000,000 +178% 31 Mar 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 250,000,000 +160,000,000 +178% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
Q3 2019 250,000,000 +160,000,000 +178% 30 Sep 2019 10-K 29 Jan 2021 2020 FY
Q2 2019 250,000,000 +160,000,000 +178% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q3
Q1 2019 90,000,000 0 0% 31 Mar 2019 10-Q 16 May 2019 2019 Q2
Q4 2018 90,000,000 0 0% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q3 2018 90,000,000 0 0% 30 Sep 2018 10-K 31 Dec 2019 2019 FY
Q2 2018 90,000,000 0 0% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 90,000,000 0 0% 31 Mar 2018 10-Q 15 May 2018 2018 Q2
Q4 2017 90,000,000 0 0% 31 Dec 2017 10-Q 12 Feb 2018 2018 Q1
Q3 2017 90,000,000 0 0% 30 Sep 2017 10-K 27 Dec 2018 2018 FY
Q2 2017 90,000,000 0 0% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 90,000,000 0 0% 31 Mar 2017 10-Q 12 May 2017 2017 Q2
Q4 2016 90,000,000 0 0% 31 Dec 2016 10-Q 13 Feb 2017 2017 Q1
Q3 2016 90,000,000 0 0% 30 Sep 2016 10-K 29 Dec 2017 2017 FY
Q2 2016 90,000,000 -810,000,000 -90% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q3
Q1 2016 90,000,000 -810,000,000 -90% 31 Mar 2016 10-Q 16 May 2016 2016 Q2
Q4 2015 90,000,000 -810,000,000 -90% 31 Dec 2015 10-Q 19 Feb 2016 2016 Q1
Q3 2015 90,000,000 0 0% 30 Sep 2015 10-K 09 Jan 2017 2016 FY
Q2 2015 900,000,000 0 0% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q3
Q1 2015 900,000,000 +850,000,000 +1700% 31 Mar 2015 10-Q 13 May 2015 2015 Q2
Q4 2014 900,000,000 +850,000,000 +1700% 31 Dec 2014 10-Q 27 Jan 2015 2015 Q1
Q3 2014 90,000,000 -810,000,000 -90% 30 Sep 2014 10-K 13 Jan 2016 2015 FY
Q2 2014 900,000,000 +850,000,000 +1700% 30 Jun 2014 10-Q 14 Jul 2014 2014 Q3
Q1 2014 50,000,000 0 0% 31 Mar 2014 10-Q 12 May 2014 2014 Q2
Q4 2013 50,000,000 0 0% 31 Dec 2013 10-Q 07 Jan 2014 2014 Q1
Q3 2013 900,000,000 +850,000,000 +1700% 30 Sep 2013 10-K 25 Nov 2014 2014 FY
Q2 2013 50,000,000 0 0% 30 Jun 2013 10-Q 13 Aug 2013 2013 Q3
Q1 2013 50,000,000 0 0% 31 Mar 2013 10-Q 20 May 2013 2013 Q2
Q4 2012 50,000,000 0 0% 31 Dec 2012 10-Q 19 Feb 2013 2013 Q1
Q3 2012 50,000,000 0 0% 30 Sep 2012 10-K 30 Dec 2013 2013 FY
Q2 2012 50,000,000 0 0% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q3
Q1 2012 50,000,000 31 Mar 2012 10-Q 11 May 2012 2012 Q2
Q4 2011 50,000,000 31 Dec 2011 10-Q 14 Feb 2012 2012 Q1
Q3 2011 50,000,000 30 Sep 2011 10-K 11 Jan 2013 2012 FY
Q2 2011 50,000,000 30 Jun 2011 10-Q/A 07 Sep 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.